Ningbo Menovo Pharmaceutical Co., Ltd.

XSSC:603538 Stock Report

Market Cap: CN¥2.9b

Ningbo Menovo Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Cheng Zhi Yao

Chief executive officer

CN¥606.0k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership5.7%
Management average tenureno data
Board average tenure5.9yrs

Recent management updates

Recent updates


CEO

Cheng Zhi Yao (49 yo)

no data

Tenure

CN¥606,000

Compensation

Mr. Yao, Cheng Zhi serves as Chairman of the Board and General Manager at Ningbo Menovo Pharmaceutical Co., Ltd.


Board Members

NamePositionTenureCompensationOwnership
Cheng Zhi Yao
GM & Chairmanno dataCN¥606.00k5.66%
CN¥ 161.7m
Gaofeng Ying
Directono dataCN¥268.50k0.046%
CN¥ 1.3m
Qian Cao
Director5.9yrsCN¥546.70k0.12%
CN¥ 3.5m
Zi Min Ye
Independent Director5.9yrsCN¥80.50kno data
Hui Lin Li
Independent Director5.9yrsCN¥80.50kno data
Xinmin Bao
Independent Director5.9yrsCN¥80.50kno data
Sibin Liu
Supervisory Board Chairman3yrsno data0.00079%
CN¥ 22.6k
Lingna Shu
Employee Supervisor2.3yrsno data0.000070%
CN¥ 2.0k

5.9yrs

Average Tenure

52yo

Average Age

Experienced Board: 603538's board of directors are considered experienced (5.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.